Výsledky vyhľadávania - "Glioma/complications"

  1. 1
  2. 2
  3. 3

    Zdroj: Neuro Oncol
    Boele, F W, den Otter, P W M, Reijneveld, J C, de Witt Hamer, P C, van Thuijl, H F, Lorenz, L M C, Wesseling, P, Lagerwaard, F J, Taphoorn, M J B, Kouwenhoven, M C M, Snijders, T J, Douw, L & Klein, M 2023, 'Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers : A longitudinal study spanning two decades', Neuro-Oncology, vol. 25, no. 2, pp. 351-364. https://doi.org/10.1093/neuonc/noac185, https://doi.org/10.1093/neuonc/noac185

    Popis súboru: application/pdf

  4. 4
  5. 5
  6. 6
  7. 7

    Zdroj: Caramanna, I, Bottomley, A, Drijver, A J, Twisk, J, van den Bent, M, Idbaih, A, Wick, W, Pe, M, Klein, M, Reijneveld, J C & EORTC Quality of Life Group and Brain Tumour Group 2021, 'Objective neurocognitive functioning and neurocognitive complaints in patients with high-grade glioma : Evidence of cognitive awareness from the European Organisation for Research and Treatment of Cancer brain tumour clinical trials', European Journal of Cancer, vol. 144, pp. 162-168. https://doi.org/10.1016/j.ejca.2020.10.040

    Popis súboru: application/pdf

  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Zdroj: Sørensen, M F, Heimisdóttir, S B, Sørensen, M D, Mellegaard, C S, Wohlleben, H, Kristensen, B W & Beier, C P 2018, ' High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma ', Journal of Neuro-Oncology, vol. 138, no. 1, pp. 49–53 . https://doi.org/10.1007/s11060-018-2785-9

  16. 16
  17. 17
  18. 18
  19. 19
  20. 20